QBiotics
QBiotics is a Australia-based biotechnology company running 2 late-stage cancer trials in sarcomas and head and neck squamous cell carcinoma.
Overview
QBiotics, based in Toowong, Brisbane, Australia, is a biotechnology company. QBiotics discovers and develops novel cell-signalling small molecules using phenotypic screening, with programmes in oncology, wound healing and antibiotic discovery. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials in sarcomas and head and neck squamous cell carcinoma. The largest, NCT05755113 (A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma), plans to enrol 40 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyEpicentRx
Shares Sarcomas (soft tissue, bone, GIST), Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyRanok Therapeutics (Hangzhou)
Shares Sarcomas (soft tissue, bone, GIST) and the tag ctgov-sponsor.
- CompanyAveta Biomics
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyRakuten Medical
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyAP Biosciences
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyTiumBio
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyPhilogen S.p.A.
Shares Sarcomas (soft tissue, bone, GIST) and the tag ctgov-sponsor.
- CompanyScancell
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.